104 related articles for article (PubMed ID: 17764935)
1. Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production.
Van Camp JA; Hu LY; Kostlan C; Lefker B; Li J; Mitchell L; Wang Z; Yue WS; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
Bioorg Med Chem Lett; 2007 Oct; 17(20):5529-32. PubMed ID: 17764935
[TBL] [Abstract][Full Text] [Related]
2. 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production.
Mitchell L; Wang Z; Hu LY; Kostlan C; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
Bioorg Med Chem Lett; 2009 Mar; 19(5):1310-3. PubMed ID: 19201190
[TBL] [Abstract][Full Text] [Related]
3. Diphenyl ethers as androgen receptor antagonists for the topical suppression of sebum production.
Mitchell LH; Hu LY; Nguyen M; Fakhoury S; Smith Y; Iula D; Kostlan C; Carroll M; Dettling D; Du D; Pocalyko D; Wade K; Lefker B
Bioorg Med Chem Lett; 2009 Apr; 19(8):2176-8. PubMed ID: 19286380
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production.
Hu LY; Lei HJ; Du D; Johnson TR; Fedij V; Kostlan C; Yue WS; Lovdahl M; Li JJ; Carroll M; Dettling D; Asbill J; Fan C; Wade K; Pocalyko D; Lapham K; Yalamanchili R; Samas B; Vrieze D; Ciotti S; Krieger-Burke T; Sliskovic D; Welgus H
Bioorg Med Chem Lett; 2007 Oct; 17(20):5693-7. PubMed ID: 17766112
[TBL] [Abstract][Full Text] [Related]
5. Pantolactams as androgen receptor antagonists for the topical suppression of sebum production.
Sexton KE; Barrett S; Bridgwood K; Carroll M; Dettling D; Du D; Fakhoury S; Fedij V; Hu LY; Kostlan C; Pocalyko D; Raheja N; Smith Y; Shanmugasundaram V; Wade K
Bioorg Med Chem Lett; 2011 Sep; 21(18):5230-3. PubMed ID: 21831636
[TBL] [Abstract][Full Text] [Related]
6. Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications.
Li JJ; Iula DM; Nguyen MN; Hu LY; Dettling D; Johnson TR; Du DY; Shanmugasundaram V; Van Camp JA; Wang Z; Harter WG; Yue WS; Boys ML; Wade KJ; Drummond EM; Samas BM; Lefker BA; Hoge GS; Lovdahl MJ; Asbill J; Carroll M; Meade MA; Ciotti SM; Krieger-Burke T
J Med Chem; 2008 Nov; 51(21):7010-4. PubMed ID: 18921992
[TBL] [Abstract][Full Text] [Related]
7. Rational design of a topical androgen receptor antagonist for the suppression of sebum production with properties suitable for follicular delivery.
Mitchell LH; Johnson TR; Lu GW; Du D; Datta K; Grzemski F; Shanmugasundaram V; Spence J; Wade K; Wang Z; Sun K; Lin K; Hu LY; Sexton K; Raheja N; Kostlan C; Pocalyko D
J Med Chem; 2010 Jun; 53(11):4422-7. PubMed ID: 20462217
[TBL] [Abstract][Full Text] [Related]
8. (1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production.
Hu LY; Du D; Hoffman J; Smith Y; Fedij V; Kostlan C; Johnson TR; Huang Y; Kesten S; Harter W; Yue WS; Li JJ; Barvian N; Mitchell L; Lei HJ; Lefker B; Carroll M; Dettling D; Krieger-Burke T; Samas B; Yalamanchili R; Lapham K; Pocalyko D; Sliskovic D; Ciotti S; Stoller B; Hena MA; Ding Q; Maiti SN; Stier M; Welgus H
Bioorg Med Chem Lett; 2007 Nov; 17(21):5983-8. PubMed ID: 17827000
[TBL] [Abstract][Full Text] [Related]
9. 7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
Zhang P; Kern JC; Terefenko EA; Fensome A; Unwalla R; Zhang Z; Cohen J; Berrodin TJ; Yudt MR; Winneker RC; Wrobel J
Bioorg Med Chem; 2008 Jul; 16(13):6589-600. PubMed ID: 18504132
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 7alpha-substituted dihydrotestosterones as androgen receptor pure antagonists and their structure-activity relationships.
Tachibana K; Imaoka I; Yoshino H; Emura T; Kodama H; Furuta Y; Kato N; Nakamura M; Ohta M; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
Bioorg Med Chem; 2007 Jan; 15(1):174-85. PubMed ID: 17064916
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists.
Xiao HY; Balog A; Attar RM; Fairfax D; Fleming LB; Holst CL; Martin GS; Rossiter LM; Chen J; Cvjic ME; Dell-John J; Geng J; Gottardis MM; Han WC; Nation A; Obermeier M; Rizzo CA; Schweizer L; Spires T; Shan W; Gavai A; Salvati ME; Vite G
Bioorg Med Chem Lett; 2010 Aug; 20(15):4491-5. PubMed ID: 20584610
[TBL] [Abstract][Full Text] [Related]
13. The synthesis and biological evaluation of some caffeic acid amide derivatives: E-2-cyano-(3-substituted phenyl)acrylamides.
Zhou W; Li HB; Xia CN; Zheng XM; Hu WX
Bioorg Med Chem Lett; 2009 Apr; 19(7):1861-5. PubMed ID: 19272773
[TBL] [Abstract][Full Text] [Related]
14. 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors.
Berger DM; Dutia M; Powell D; Floyd MB; Torres N; Mallon R; Wojciechowicz D; Kim S; Feldberg L; Collins K; Chaudhary I
Bioorg Med Chem; 2008 Oct; 16(20):9202-11. PubMed ID: 18815050
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands.
Van Dort ME; Jung YW
Bioorg Med Chem Lett; 2001 Apr; 11(8):1045-7. PubMed ID: 11327585
[TBL] [Abstract][Full Text] [Related]
16. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands.
Van Dort ME; Jung YW
Bioorg Med Chem Lett; 2004 Nov; 14(21):5285-8. PubMed ID: 15454212
[TBL] [Abstract][Full Text] [Related]
19. 2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Mantri M; de Graaf O; van Veldhoven J; Göblyös A; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Link R; de Vries H; Beukers MW; Brussee J; Ijzerman AP
J Med Chem; 2008 Aug; 51(15):4449-55. PubMed ID: 18637670
[TBL] [Abstract][Full Text] [Related]
20. Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists.
Tachibana K; Imaoka I; Yoshino H; Kato N; Nakamura M; Ohta M; Kawata H; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
Bioorg Med Chem Lett; 2007 Oct; 17(20):5573-6. PubMed ID: 17804229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
